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Abstract Pain is the most common reason why patients see a
physician. Within the USA, it has been estimated that at least
116 million US adults suffer from chronic pain, with an esti-
mated annual national economic cost of $560–635 billion.
While pain is in part a sensory process, like sight, touch, or
smell, pain is also in part an emotional experience, like depres-
sion, anxiety, or anger. Thus, chronic pain is arguably the
quintessential biopsychosocial condition. Due to the over-
whelming evidence of the biopsychosocial nature of pain and
the value of psychological assessments, the majority of chronic
pain guidelines recommend a psychological evaluation as an
integral part of the diagnostic workup. One biopsychosocial
inventory designed for the assessment of patients with chronic
pain is the Battery for Health Improvement 2 (BHI 2). The BHI
2 is a standardized psychometric measure, with three validity
measures, 16 clinical scales, and a multidimensional assess-
ment of pain. This article will review how the BHI 2 was
developed, BHI 2 concepts, validation research, and an over-
view of the description and interpretation of its scales. Like all
measures, the BHI 2 has strengths and weaknesses of which the
forensic psychologist should be aware, and particular purposes
for which it is best suited. Guided by that knowledge, the BHI 2
can play a useful role in the forensic psychologist’s toolbox.
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Pain is the most common reason why patients see a physician:
Something hurts (Centers for Disease Control and Prevention
2010; National Center for Health Statistics 1992). Thus, the
presence of pain is a primary driving force that underlies the
demand for health care. Within the USA, it has been estimated
that at least 116 million US adults suffer from chronic pain,
with an estimated annual national economic cost of $560–635
billion (Institute of Medicine 2011). Chronic pain is also
closely associated with disability (Ehde et al. 2003; Zale
et al. 2013). In 2012, 10.8 million persons were receiving
Social Security Disability Income (SSDI), at the cost of
$128 billion annually, not including the associated costs of
Medicare (Congressional Budget Office 2012). Of SSDI re-
cipients in 2011, 44 % were prescribed opioid pain relievers
(Morden et al. 2014).
A recent report from the Institute of Medicine studied the
problem of pain in the USA. It concluded that pain has
biological, psychological, and social components, and effec-
tive treatments for pain must address all three of these com-
ponents. This report stated that “effective pain management is
a moral imperative, a professional responsibility, and the duty
of people in the healing professions” (Institute of Medicine
2011; p. S-3). The International Association for the Study of
Pain has affirmed the biopsychosocial nature of pain and
concluded that pain has a dual nature. While pain is in part a
sensory process, like sight, touch, or smell, pain is also in part
an emotional experience, like depression, anxiety, or anger
(Merskey and Bogduk 1994). At the neurophysiological level,
the experience of pain is inextricably linked with physiolog-
ical arousal, mood, memory, and cognition (Apkarian et al.
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2009; Melzack 2001). Thus, chronic pain represents the quin-
tessential biopsychosocial condition.
One of the challenges of treating patients with chronic pain
is that pain leads to increased demand for opioid medication to
suppress the pain, and surgical interventions to “fix” the pain.
Unfortunately, due to pain’s complex nature, iatrogenic com-
plications are common. One study examined the number of
unintentional deaths in the USA from prescription opioid pain
medications and found that it exceeds the number of deaths
due to cocaine and heroin combined (Centers for Disease
Control and Prevention 2012). Another study examining the
effects of surgical treatments for patients with spinal pain
found that while an objectively successful fusion occurred in
84 % of lumbar fusion patients, nearly half were dissatisfied
with their outcome, and many were totally disabled at follow-
up (LaCaille et al. 2005). Because pain treatments such as
these can lead to iatrogenic complications, these treatments
can be both costly and counter-productive.
The study by LaCaille and colleagues above illustrates an
important conclusion of another study. In many cases, ortho-
pedic surgeries for chronic pain are performed when the
primary outcome goals are to change behavior: to induce the
patient to say, “My pain is much better,” to say, “I don’t need
opioids anymore,” to report satisfaction with health care, or to
return to work (Bruns and Disorbio 2009). While medical
imaging techniques are helpful for making objective diagno-
ses, these imaging techniques were not designed to assess
feelings or predict behavior. Consequently, pain self-reports
cannot be replaced by neuroimaging or other technologies
(Robinson et al. 2013). Given the prominent psychological
component of chronic pain, the advice of Hippocrates is
especially apt: “It is more important to know what sort of
person has a disease, than to know what sort of disease a
person has” (Hippocrates, 400 BCE). Thus, since chronic pain
is known to be a complex, biopsychosocial condition, a pre-
requisite of effective pain treatment is accurate assessment of
not only the medical aspects of pain but also the psychosocial
aspects as well.
Psychological interventions for chronic pain have been
shown to be safe and effective treatments for pain (Hoffman
et al. 2007) but are generally underutilized (Robbins et al.
2003). Studies have shown that psychological treatments
combined with exercise can produce improvements in func-
tioning that equal those of surgery for back pain (Brox et al.
2010; Chou et al. 2009). The economic benefits of a treatment
model that integrated psychological services was tested in a
15-year longitudinal study of 29 million patients, which pro-
vided evidence that a biopsychosocial model for treating pain
and injury provided better care at less cost (Bruns et al.
2012b). This model relied heavily on psychological assess-
ments for treatment planning.
An extensive review of the evidence determined that psy-
chological tests are the scientific equal of medical tests (G. J.
Meyer et al. 2001) and can sometimes exceed the ability of
medical tests to predict the outcome of medical treatments for
pain (Carragee et al. 2005; Carragee et al. 2004). Due to the
overwhelming evidence for the biopsychosocial nature of pain
and the value of psychological assessments, the majority of
chronic pain guidelines recommend a psychological evalua-
tion as an integral part of the diagnostic workup (Bruns in
press). These guidelines create a mandate for both clinical and
forensic psychological evaluations of chronic pain.
Psychological assessments for medical patients serve a
number of purposes. These include providing an accurate
means of describing a medical patient’s mental status, medical
symptoms, traits, attitudes, abilities, and the patient’s percep-
tion of the social environment. This in turn can facilitate
making determinations about how to diagnose or classify the
patient, plan interventions, predict outcome, and measure
change (Bruns in press; Bruns and Disorbio 2013; Turner
et al. 2001). One biopsychosocial inventory designed for the
assessment of patients with chronic pain is the Battery for
Health Improvement 2 (BHI 2) (Bruns and Disorbio 2003).
The BHI 2 is a standardized psychometric measure, a primary
purpose of which is to perform clinical and forensic evalua-
tions of patients with pain and injury. This article will provide
an overview of how the BHI 2 was developed, BHI 2 inter-
pretive concepts, and the nature and validation of its scales.
Overview of the BHI 2
The goal of the BHI 2 development was to create a compre-
hensive biopsychosocial inventory to assess medical patients
with pain and/or injury specifically, and somatic symptom
disorders more generally. Consequently, the BHI 2 is best
conceptualized not as a psychological inventory, but rather
as a biopsychosocial inventory.
A brief review of the BHI 2’s development and validation
process (Bruns and Disorbio 2003) is as follows:
1. The BHI 2 originated with a paradigm called the vortex
model, which is a graphical representation of the
biopsychosocial model as it pertains to the onset of injury,
illness, chronic pain, and intractable biopsychosocial dis-
orders (Fig. 1). This model attempted to organize what
was known about how patients respond to health chal-
lenges, and why some patients get into a “downward
spiral” of worsening symptoms. The vortex model served
as a guide for BHI 2 development, and as a conceptual
paradigm for performing a biopsychosocial evaluation in
the clinical setting.
2. Development of the BHI 2 began when, based on this
biopsychosocial paradigm, over 1,100 items were gen-
erated, of which 600 were selected for empirical
assessment.
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3. The 600 selected items were administered to 2,507 sub-
jects gathered from 106 sites in 36 US states, along with
a number of other measures. Information from treating
providers was also gathered.
4. From the overall sample, patient and community devel-
opment groups were identified, and these were used to
explore the psychometrics of the prototypical BHI 2
scales.
5. Later, patient and community normative groups were
also developed and were stratified to match US Census
data for age, gender, race, and education. These two
norm groups serve as estimates of the responses of the
average American patient with pain or injury, and the
average American community member.
6. Eight other reference groups were also identified. From
the patient norm group, subgroups for chronic pain, head
injury/headache pain, neck pain, upper extremity pain,
low back pain, and lower extremity pain were identified.
Additionally, fake good and fake bad groups were also
obtained.
7. The scales to develop were identified through a review
of the literature and were represented in the vortex
paradigm. The BHI 2’s scales are organized in accor-
dance with the biopsychosocial model, and the content
of the scales and items were developed to represent the
various aspects of the paradigm.
8. Items were assigned to the 18 BHI 2 scales based on the
appropriateness of the item content, and the ability of the
item to differentiate one group of subjects from another,
item to scale correlations, item to criteria correlations,
and resultant scale to criteria correlations.
9. The BHI 2 development process produced three validity
measures (Validity Items (random responding), Self-
Disclosure, and Defensiveness), “biological” scales
assessing medical symptoms (Somatic Complaints,
Pain Complaints, Functional Complaints, and Muscular
Bracing), psychological measures of affect and charac-
terological dysfunction (Depression, Anxiety, Hostility,
Border l ine , Symptom Dependency, Chronic
Maladjustment, Substance Abuse, and Perseverance),
and measures of the patient’s social environment
(Family Dysfunction, Doctor Dissatisfaction, Survivor
of Violence, and Job Dissatisfaction). At cross-valida-
tion, the mean test-retest reliability and Cronbach’s alpha
of the BHI 2 scales were .93 and .84, respectively.
10. The development process also yielded 40 content-based
subscales. Items were assigned to these subscales based
on the appropriateness of the item content as determined
by the opinion of a panel of 12 expert judges. The
description of these scales goes beyond the scope of this
paper. However, the content validity established by this
method supported the content validity of the parent scale
of which the subscale is a part. The mean test-retest
reliability, Cronbach’s alpha, and interjudge agreement
regarding item content of the BHI 2 content-based sub-
scales were .88, .69, and .92, respectively.
11. Following the completion of the test development pro-
cess, the BHI 2 has been the subject of numerous peer-
reviewed studies about variousmatters of clinical interest.
12. Because the BHI 2 scales were validated in different
ways, validity is a more complex topic and will be
discussed on a scale-by-scale basis below.
Along with tests such as the Minnesota Multiphasic
Personality Inventory-2-RF (Ben-Porath and Tellegen 2011),
the Millon Clinical Multiaxial Inventory III (Millon et al.
1997), and the Millon Behavioral Medicine Diagnostic
(Millon et al. 2001), the BHI 2 has been listed as a commonly
used test for patients with chronic pain in multiple medical
treatment guidelines (American College of Occupational and
Environmental Medicine 2008; California Division of
Workers' Compensation 2009; Colorado Division of
Workers' Compensation 2012; Oklahoma Physician
Advisory Committee 2007; Work Loss Data Institute 2009),
has been integrated into clinical protocols (Bruns and Disorbio
2013), and was favorably peer reviewed by the Buros Center
for Testing (Vitelli 2007). This review concluded that the BHI
2 could benefit from further studies about validity assessment
and malingering, and longitudinal studies about medical treat-
ment outcome. Despite these weaknesses, the review conclud-
ed that “the reliability and validity research of the BHI 2
demonstrates that it is one of the best instruments available
for assessing the broad range of treatment needs in clinical
populations” (Vitelli 2007; p. 75).
At the time of this writing, the BHI 2 or Brief BHI 2 (BBHI
2) has been accepted as evidence in several US federal court
cases (Chambers v. Astrue 2013; Cowgar v. Commissioner Of
Social Security Administration 2008; Cowger v. Astrue 2008;
Davis v. Astrue 2009; Lewis v. Astrue 2012; Webb v. Astrue
2009). The short version of the BHI 2, the Brief Battery for
Health Improvement 2 (BBHI 2), has been accepted as evi-
dence in one US federal case (McGuire v. Astrue 2008).
Although the BHI 2 and BBHI 2 have been accepted as
evidence in federal courts, there have been no specific judicial
rulings pertaining to the tests themselves. However, in one
case, one psychologist’s testimony was determined to be more
persuasive than that of a second psychologist due to the fact
that the first psychologist had performed validity testing,
which included the BHI 2 scales (Webb v. Astrue). In two
other cases, testimony was given that the BHI 2 “is a more
sophisticated test” than the Beck Depression Inventory
(Cowgar v. Commis s i one r O f Soc ia l Secur i t y
Administration; Cowger v. Astrue).1
1 Note that the opinion Cowgar v. Commissioner Of Social Security
Administration was filed with a typo, misspelling “Cowger.”
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Bidirectional Scales and the Interpretation of Low Scores
Many human traits and symptoms are more or less normally
distributed, and scores that deviate from the mean in either the
high or low direction are equally “abnormal” in the statistical
sense. Similar to measures of cognitive ability, where both
high and low scores are meaningful, some measures of mood
or personality also return a near normal distribution of scores,
where high and low scores are of equal significance (McCrae
et al. 2010; Russell et al. 2002). Scales which produce mean-
ingful high and low scores are sometimes called “bipolar
scales” (Widiger 2011), but to avoid confusion with the diag-
nosis of the same name, the term “bidirectional scales”will be
preferred here. Recent research has suggested that conceptu-
alizing psychological measures as being unidirectional may be
mistaken, as maladaptive traits can be observed in patients
with scores at both ends of a scale’s distribution (Pettersson
et al. 2014). For example, one study concluded that on a
neuroticism scale (measuring high negative affectivity), a
low score was suggestive of the glib and fearless traits seen
in psychopaths. Thus, both very high and very low scores on
this scale were indicative of psychological dysfunction
(Widiger 2011).
Bidirectional scales would appear to be of particular inter-
est in the assessment of patients with chronic pain, or
somatoform or somatic symptom disorders. This is because
unusually low scores on somemeasures may suggest denial or
suppressed report, and numerous studies have associated cog-
nitive and emotional suppression with heightened psycho-
physiological reactivity and symptom report.
Studies have found that thought suppression increases the
occurrence of obsessive ruminations about the very subject
that the patient is trying to ignore (Wegner 1994; Wegner and
Lane 2002). The avoidance of talking about strong feelings or
important experiences has also been associated with autonom-
ic arousal. For example, studies have found that suppressed
anger increased blood pressure more than manifest anger
(Vogele et al. 1997) and is also associated with increased pain
(Quartana et al. 2010). The suppression of negative emotions
is also associated with compromised functioning of the im-
mune system (Petrie et al. 2002; Petrie et al. 1998), while
emotional inhibition and reports of unusually low stress are
associated with elevated levels of muscular bracing and
myofascial pain (Traue 2002). Other studies have demonstrat-
ed that emotional repression predicts poor outcome following
multidisciplinary treatment for chronic pain (Burns 2000),
higher levels of cardiac reactivity (Burns et al. 1999), hyper-
tension (Gleiberman 2007), and with behavioral signs of
anxiety (Giese-Davis et al. 2014). A factor analytic study of
patients with chronic pain identified one factor consisting of
patients with high pain and disability but an absence of emo-
tional distress (Burns et al. 2001). Patients who suppress
emotions are also less likely to recall undesirable information
about their health (Millar 2006). Overall, while the interpre-
tation of low scores is the cornerstone of neuropsychological
assessment, the interpretation of low scores/low reports is
often overlooked when assessing patients with chronic pain.
Diagnostically, unusually low affective reports have been
associated with a personality construct called “alexithymia,”
meaning “without words for feelings” (Sifneos 1996).
Research has established that alexithymia includes difficulty
identifying or describing feelings, externally oriented think-
ing, and a limited capacity for imagination (Lumley et al.
2007). Two studies have concluded that there is a consistent
link between alexithymia and somatization (Allen et al. 2011;
Bailey and Henry 2007), while other studies concluded that
alexithymia contributes to the emergence of somatic symp-
toms in major depression (Gulec et al. 2013), to somatization
after brain injury (Wood et al. 2009), to unrecognized affective
distress associated with pain (Lumley et al. 2002), to increased
illness behavior (Lumley et al. 1997), and to stronger electro-
dermal response in biofeedback (Friedlander et al. 1997). This
relationship between alexithymia and somatization was also
supported by the findings of a large population study (Mattila
et al. 2008). Although neither the DSM-5 (American
Psychiatric Association 2013), DSM-IV (American
Psychiatric Association 2000), nor the ICD-10 (World
Health Organization 2010) mentions alexithymia, all note that
some somatizing patients may exhibit unexpectedly low levels
of affective distress, which is consistent with the above.
As an example of the effects of unrecognized affec-
tive distress, a patient who is having an anxiety attack
could state emphatically that the symptoms are not due
to severe stress or anxiety and instead assert that she/he
is having a heart attack. In such a scenario, the patient
may report extremely high physical distress but deny or
be unaware of the emotional origins of the symptom.
The research reviewed above suggests that the denial of
the affective component may actually increase the so-
matic component of the symptoms, and this suggests a
need for the assessment of low affective scores.
Although some of the BHI 2 scales exhibit a truncated
distribution of scores below the mean, and a positive skew
(e.g., Pain Complaints, Substance Abuse, and Survivor of
Violence), some are close to being normally distributed, with
other scales exhibiting a negative skew (e.g., Defensiveness,
Anxiety, and Perseverance) (Table 1). One BHI 2 scale,
Perseverance, is negatively skewed to the degree that negative
T scores are possible (which occurs when a T score is more
than 5 standard deviations below the mean). Statistically,
scores which are 5 standard deviations below the mean are
just as “abnormal” as scores which are 5 standard deviations
above, and the studies reviewed above suggest that such
unusually low scores might be as clinically meaningful as
high ones. The interpretation of such low scores is sometimes
less clear, though.
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While moderately low scores on the BHI 2 or other psy-
chological measures may reflect that the patient is coping
unusually well, as scores become very low or extremely low,
a different type of adjustment problem may be indicated. For
example, an utter absence of any perceived affective distress
could be explained as being attributable to extraordinary re-
silience, or alternately to psychopathy, alexithymia, denial, or
dissociation. In the clinical setting, as each of these alterna-
tives is associated with different behaviors, behavioral obser-
vations and the patient’s history might be needed to help
determine which interpretation is correct.
On all of the BHI 2 scales, the lowest possible raw score is
0, and this can be a useful benchmark in interpretation. For
example, in order for a patient to receive a raw score of 0 on
Hostility, the patient must have strongly disagreed with 16
items having to do with anger. If, in an interview, a patient
denied ever having any angry thoughts, feelings, or behaviors
16 times, it would seem remarkable. Consequently, scores this
low on the BHI 2 are empirically unusual, and often intuitively
and clinically meaningful. Even so, the interpretation of low
psychological scales scores is often problematic.
A final caveat here is that as a rule, there is far less research
on psychological measures about the interpretation of low
scores as opposed to high scores.
BHI 2 Interpretation Using Multiple Norm Groups
Any standard score compares the raw score of the individual
to some reference group, and that comparison must be refer-
enced when interpreting the score. When interpreting a pa-
tient’s score, there are two questions to answer:
The first question to answer is “how does this patient
compare to other similar patients?” To the extent that a par-
ticular patient is atypical, normal treatment protocols may not
apply. Further, knowledge of how a patient differs from a
typical patient can inform treatment decisions and assist in
the process of selecting patients for medical treatments. As a
general psychometric principle, the closer the norm group to a
patient’s status and circumstances, the more relevant the
result ing score (American Educational Research
Association, American Psychological Association, National
Council on Measurement in Education, and Joint Committee
on Standards for Educational and Psychological Testing
(U.S.) 1999).
A second question that is sometimes overlooked is “how
does this patient compare to the average healthy person?” To
assess the severity of a patient’s psychological condition, or
the degree to which a patient has been harmed by an injury, a
comparison to a healthy state is required. This is because the
effect of a medical condition cannot be seen in a comparison
to other medical patients, as all have been affected by a similar
loss of health. For example, if a patient who has had a recent
traumatic amputation reports an average level of PTSD com-
pared to other patients with traumatic amputations, this aver-
age level of PTSD does not mean that no PTSD is present.
Instead, it means that compared to other amputees, the level of
PTSD is similar. If this same patient’s PTSD score was com-
pared to the average person in the community, however, it
may be that the patient’s level of distress now appears quite
elevated. Overall, it can be seen that if the norm group is
extreme, a patient with an extreme problem will appear nor-
mal relative to that group, but that is not the same as a state of
health. This leads to the somewhat counterintuitive interpre-
tive dilemma if a PTSD scale utilized a norm group consisting
of extremely traumatized subjects, an average score would be
positive for PTSD.
A few tests used for the assessment of medical patients
attempt to address the questions above by having multiple
norm groups, notably the Minnesota Multiphasic Personality
Inventory-2 Restructured Form (MMPI-2-RF), the Millon
Behavioral Medicine Diagnostic (MBMD), and the BHI 2.
However, these tests all address this matter in different ways,
with different advantages and disadvantages. For forensic
assessment, the MMPI-2-RF includes disability litigant norms
and spinal surgery norms (Ben-Porath and Tellegen 2011),
while the MBMD utilizes both general medical and chronic
pain norms (Millon et al. 2010). The BHI 2's use of norm
groups is somewhat different than these measures, however
(Bruns and Disorbio 2003), and is described below.
As opposed to utilizing a highly specific norm group, the
BHI 2 patient norm group utilizes a more diverse cross section
of patients in treatment for pain or injury, consisting of an
approximately equal number of patients with acute injuries
and chronic pain. This group included spinal surgery patients,
nonspinal surgery patients, interventional pain medicine pa-
tients, chronic pain patients, work hardening patients, acute
pain patients, and brain injury patients, with 26 % being in
litigation. These patients were obtained from 90 sites in 30 US
states, recruiting patients from both facilities that treated
chronic pain and that treated acute injuries. Patients were
stratified to match US Census demographics (Bruns and
Disorbio 2003). This approach has broad applicability, be-
cause patients referred for spinal presurgical evaluations might
have acute conditions, while patients referred prior to spinal
cord stimulation are invariably suffering from chronic pain,
and litigation is common in the workers’ compensation and
personal injury systems. Overall, this approach produced a
psychometrically representative but less extreme normative
sample that represented an attempt to depict the average
patient in treatment for pain or injury. The second BHI 2 norm
group is the community norm group, which was also stratified
to match US Census demographics (Bruns and Disorbio
2003).
In addition to the two main normative groups, the BHI 2
also includes eight smaller, narrowly focused reference
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groups. These are chronic pain, head injury/headache, neck
injury, upper extremity injury, low back injury, lower extrem-
ity injury, fake good, and fake bad. These additional more
narrowly focused normative groups are integrated into the
interpretive analysis and used to address specific questions if
needed.
The BHI 2 differs from other multi-norm tests in that
as opposed to having the user choose between alternative
norm groups, the BHI 2 patient and community norm
groups are integrated into a single continuum. This is
accomplished in the following manner, using pain as an
example: Not surprisingly, the average patient in treatment
for pain or injury reports more pain than does the average
nonpatient in the community. Even so, there are some
Pain Complaints scores on the BHI 2 that fall within the
normal range for both the patient and community norm
groups. These levels of pain are designated as “average
scores.” As scores on the Pain Complaints scale increase,
at some point, the level of pain reported will be unusual
for a healthy person but still commonly seen in patients in
treatment for pain. As the level of Pain Complaints in-
creases further, at some point, it will also become an
unusual level of pain reports for a patient as well.
Conversely, with regard to interpreting low reports of pain,
a patient may report less pain than does the average patient in
treatment for pain or injury. As the Pain Complaints scores fall
still lower, however, the level of pain will not only be below
the typical patient in treatment, but also below that seen in the
typical healthy person, which would be particularly unusual.
Using this algorithm, the Pain Complaints scale integrates
both community and patient norms into a single continuum
(Fig. 2). The BHI 2 integrated norm profile is interpreted as
follows, utilizing the profile shown in Fig. 3:
1. The BHI 2 profile uses a deviation bar chart, where the
length of the bar represents how far the patient’s score
deviates from the mean score. Thus, statistically, the bar is
a visual representation of a z score. The longer the bar, the
more the score deviates from the mean in either a positive
or negative direction.
2. T scores within the shaded T=40 to T=60 range are
typical for the normative patient and community
samples, and approximately 68 % of the samples
scored within this range.
3. Patient T scores are represented by black diamonds. A
black diamond outside the average range indicates a level
of symptoms that is unusual for patients with pain and
injury. For unusual patients, the typical medical protocol
may not apply.
4. Community T scores are represented by white diamonds.
Awhite diamond outside the average range indicates that
the patient is different than the average nonpatient in the
community.
5. The Somatic Complaints scale score has the white dia-
mond outside the average range (indicating a high score
for community members), and the black dot inside the
average range (indicating an average score for patients).
Thus, while patients commonly report this level of
Somatic Complaints, healthy people do not.
6. In this profile, both diamonds are outside the average
range for the Pain Complaints scale. This indicates that
the patient is not only reporting more pain than the aver-
age person in the community, but also reportingmore pain
than the average patient in treatment for pain or injury.
7. The Hostility scale score was the lowest score observed in
this administration, being at the first percentile, indicating
a remarkable absence of any reported anger or irritability.
It should be noted that the raw score on this scale was 0,
the lowest possible score. Thus, the patient must have
strongly disagreed with all 16 items, which is statistically
very unusual.
In general, community norms are more sensitive with
regard to detecting low levels of problematic symptoms
than are the patient norms, but at the risk of increased false
positive findings.
Extremely high symptom level for a patient (99th %)
and extraordinarily high vs. a healthy state
Very high symptom level for a patient (95th %)
and extremely high vs. a healthy state
High symptom level for a NONpatient (84th %)
But average for a patient
Very low symptom level for a patient (5th %)
and even low for a healthier NONpatient
Average range of symptomatic complaints
reported by both patients and NONpatients
High symptom level for a patient (84th %)
and very high vs. a healthy state
Low symptom level for a patient (16th %)
But average for healthier NONpatients
Extremely low symptom level for a patient (1st %)
and even far below that seen in NONpatients
Fig. 2 The interpretive continuum of BHI 2 scale scores using integrated
patient and nonpatient norm groups
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BHI 2 Scale Interpretation
The following section provides an overview of the BHI 2 scales.
This will include a brief synopsis of the scales’ rationale and
development process, validity research, and interpretive consi-
derations. Except as otherwise noted, the information presented
below was derived from the BHI 2 validation study (Bruns and
Disorbio 2003). An overview of each scale’s reliability, and its
correlates and bidirectional skew is summarized in Table 1.
Validity Scales and Methods
Validity Items
Development The BHI 2 utilizes two separate validity condi-
tions to determine whether or not a protocol can be meaning-
fully interpreted. The first condition has to do with bizarre
responding, while the second has to do with failure to respond
(i.e., leaving items blank). With regard to the first condition,
the BHI 2 contains four Validity Items, which have extreme or
bizarre content and are rarely endorsed. While a patient with
a thought disorder might endorse one or more of these items,
an alternate interpretation is that the patient was responding in
the aberrant direction on these items due to illiteracy, random
responding, visual/cognitive problems, or poor motivation.
Scale Interpretation When a patient endorses one or more of
the Validity Items, the item is printed out for the clinician to
review along with a validity caution. If three or more of these
items are endorsed, the entire BHI 2 is regarded as invalid due
to bizarre responding. If this method determines that the BHI 2
administration is valid overall, the scales are next tested
individually.
Blank Responses
Method The second validity condition occurs when a patient
fails to respond to a number of items. Based on this method,
the BHI 2 scales are invalidated one at a time. If any scale has
25 % or more of its items left blank, that scale is judged to be
invalid and is not scored. This allows the BHI 2 to invalidate
one scale at a time based on the blank item condition, rather
than invalidate the entire test if one scale was left blank. The
BHI 2 computer algorithms will generate an interpretive re-
port of the information available if one or more scales are
valid. This reduces the risk that a test administration will
produce no usable results. If all 18 scales are invalid due to
blank items, then the entire BHI 2 protocol is invalid. Note
that if the patient is not in the workforce now or at the time of
onset of the condition, the test instructs the patient to leave the
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Fig. 3 BHI 2 profile of patient with chronic pain
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as invalid, while the remainder of the BHI 2 scales are
interpreted.
Defensiveness
Development The Defensiveness scale was developed empir-
ically to assess both positive and negative response distortions
using the following method. Patients in treatment for pain and
injury were recruited and asked to subtly fake the BHI 2 good
or bad, being cautioned that if their faking was too obvious,
they might be caught and they should try to avoid that. This
method was used as research has shown that if patients think
that they will be undergoing assessment for faking, they are
able to feign deficits in a way that is both less exaggerated and
more believable (Youngjohn et al. 1999). Both groups of
patients were then asked 475 questions, and items that were
able to significantly differentiate both fake good and fake bad
scenarios from patients were selected for the BHI 2
Defensiveness scale (Bruns and Disorbio 2003).
Scale Interpretation High scores suggest a positive bias (fak-
ing good), and low scores a negative bias (faking bad). This
scale is highly bidirectional and negatively skewed. Patients
who are low in Defensiveness are describing their life and
circumstances as terrible, while patients who are high in
Defensiveness describe their life and circumstances as great.
In either case, however, the Defensiveness scale does not
contain items pertaining to personally sensitive information,
so neither high nor low scores involve much self-disclosure.
In the validity section of the BHI 2 report, unusual
Defensiveness scores are compared to the two faking refer-
ence groups, producing a subtle fake good percentile rank or a
subtle fake bad percentile rank. This makes it possible for the
examiner to better interpret any response bias in the patient’s
BHI 2 profile.
Validity Research At cross-validation, the Defensiveness
scale was able to significantly differentiate subtle fake good
versus patient groups and subtle fake bad versus patient
groups significantly at p<.001. The Defensiveness scale cor-
related to −.56 with the MCMI-III Debasement (Z) scale, and
to −.62 with the MMPI-2 Profile Elevation. Profile Elevation
in turn is strongly associated with the MMPI 2 Disability
Profile (Gatchel et al. 2006). High and low scales here were
able to identify those asked to subtly bias the information
presented in positive and negative directions, respectively.
Self-Disclosure
Scale Development The Self-Disclosure scale was developed
to assess how much a patient was willing to disclose about
internal psychological distress. The Self-Disclosure scale was
developed from a broad index of BHI 2 items pertaining to
psychological distress and dysfunction, which excluded items
about physical symptoms or social conflicts. It is conceptually
similar to the MCMI-III Disclosure scale.
Scale Interpretation High scores indicate that the patient is
disclosing an unusually high level of information about psy-
chological dysfunction. In the clinical setting, patients with
high Self-Disclosure scores are likely to be very open about
conveying their internal psychological distress and dysfunc-
tion, sometimes to the point of self-debasement, and are often
seeking help. Low scores suggest an unusual absence of any
reported psychological difficulties. Patients with low levels of
Self Disclosure are psychologically more guarded and private,
may have concerns about who has access to the information
that will be disclosed, and might not be motivated to share
much personal information with the examiner.
Validity Research At cross-validation, the Self-Disclosure
scale was able to significantly differentiate fake good versus
patient groups and fake bad versus patient groups significantly
at p<.001. The Self-Disclosure scale is correlated to .66 and
.62 with the MCMI-III Disclosure (X) and Debasement (Z)
scales, respectively, and to .69 with the MMPI-2
Dissimulation (F–K) index, to .58 with the Infrequency (F),
and to −.57 with the Correction (K) scale. Very high BHI 2
Self Disclosure scores (indicating a very high level of reported
psychological distress) have been identified as a possible
indication of malingering (Rogers 2008).
Physical Symptom Scales
The BHI 2 is a biopsychosocial inventory that assesses physi-
cal, psychological, and social variables. On the BHI 2, the Pain
Complaints, Somatic Complaints, Functional Complaints, and
Muscular Bracing scales assess physical symptomatology. The
BHI 2 test administration begins with the Pain Complaints
scale, followed by the Somatic Complaints scale. Since the
presenting concern of medical patients is their physical symp-
toms, this begins the test administration with the likely area of
their primary concern. It was hoped that this would reduce
patient resistance to completing the inventory.
Pain Complaints
Development Pain is assessed in two primary ways in clinical
settings: numerical rating scales and pain drawings. At the
time of this writing, a Medline search for “VAS” or “NRS”
and “pain” yielded 13,664 articles, demonstrating that this
approach to pain assessment is ubiquitous. In contrast to uni-
dimensional ratings, scored pain drawing methods rely entire-
ly or in part on the number of body sites with pain (Takata and
Hirotani 1995), and widespread pain predicts disability
(Gerdle et al. 2008; Grotle et al. 2010; Kamaleri et al. 2009;
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Overland et al. 2012), inactivity (McBeth et al. 2010), com-
plaints of nonmusculoskeletal medical problems (Kadam et al.
2005), greater medical utilization (Kadam et al. 2005), auto-
nomic dysfunction (McBeth et al. 2007), occupational disabil-
ity (Mayer et al. 2008), Waddell signs (Chan et al. 1993),
treatment outcome (Takata and Hirotani 1995; Voorhies et al.
2007), performance on isokinetic measures of strength and
function (Ohnmeiss et al. 2000), and continuing chronic pain
12 years in the future (Andersson 2004). As pain has been
identified by two systemic reviews as an important predictor
of poor outcome from spinal surgery (Celestin et al. 2009; den
Boer et al. 2006), a principle goal of the BHI 2 was to develop
a multidimensional assessment of pain. The BHI 2 utilizes a
hybrid approach to assess both pain intensity like a VAS/NRS,
and pain distribution like a pain drawing. To accomplish this,
the BHI 2 Pain Complaints scale asks about pain intensity in
ten different body areas, which provides a composite score.
Interpretation High scores on the Pain Complaints scale in-
dicate widespread pain in multiple body areas. This pattern of
diffuse pain complaints can be observed in patients with
diffuse rheumatoid arthritis, fibromyalgia, and chronic pain
generally. This diffuse pattern of pain is difficult to explain in
patients with a localized injury and suggests the possibility
that central sensitization2 may be contributing to pain percep-
tion. Low scores on the Pain Complaints scale indicate that the
patient is unusually pain free, possibly suggesting stoicism or
reluctance to share information about pain.
Validity Research The Pain Complaints scale correlated to .70
with a scored pain drawing, and to .61 with the McGill Pain
Questionnaire. The number of body areas with pain on this
scale was also determined by one study to be a significant
predictor of a failure to make functional improvements fol-
lowing interdisciplinary treatment (Freedenfeld et al. 2002).
Patients who are faking good tend to get lower scores on Pain
Complaints (Disorbio et al. 2014). Patients with both cancer-
related and noncancer-related breakthrough pain also scored
higher on Pain Complaints (Portenoy et al. 2010).
Other BHI 2 Pain Measures
Highest Pain, Lowest Pain, and Pain Now Similar to the
Brief Pain Inventory (Cleeland 2009), the BHI 2 asks the
patient to rate his/her highest, lowest, and current pain levels.
BHI 2 Highest Pain levels have been positively associated
with breakthrough pain (Portenoy et al. 2010), with wanting
pain medication (Bruns et al. 2013), with medication noncom-
pliance (Bruns et al. 2013), with smoking (Fishbain et al.
2013), with pain catastrophizing (Bruns et al. 2013), and with
both delayed sleep onset and frequent awakenings (Bruns and
Bruns 2011).
Pain Range Pain Range assesses the variability of the pa-
tient’s pain complaints by comparing the difference between
the patient’s highest and lowest pain reports in the last month.
If a patient’s Pain Range score is empirically low (<2), the
patient is saying that his/her pain has been remarkably invari-
ant over the course of the last month (i.e., “my pain never
changes”), which is empirically unusual but would be consis-
tent with the theory that chronic pain is often not a sensory
experience, and has been more closely associated with mem-
ory (Apkarian et al. 2009). If Pain Range is high (>6), it raises
the question as to what circumstances produce the unusual
pain variation. One study found that pain variability is asso-
ciated with depression and more severe pain (Zakoscielna and
Parmelee 2013). However, the BHI 2 Pain Range measure has
not been empirically investigated itself.
Pain Tolerance Index The Pain Tolerance Index (PTI) is a
BHI 2 measure of pain intolerance. The BHI 2 PTI score
correlated significantly with depression, anxiety, somatiza-
tion, quality of life, disability, pain interference, and with
physical difficulties with functioning (Bruns et al. 2005).
PTI norms and reliability have been developed (Disorbio
et al. 2013).
Pain Diagnostic Category In the clinical setting, pain
drawings are judged by visual inspection with regard to
the degree that they are displaying an “anatomical distri-
bution” or not. In contrast, the BHI 2 assessment of the
“anatomical distribution” of pain reports utilizes a comput-
erized empirical approach. This analysis utilizes five BHI
2 pain normative groups, which are head injury/headache,
neck injury, upper extremity injury, low back injury, and
lower extremity injury. This approach mathematically com-
pares the distribution of a patient’s 10 pain reports on the
BHI 2 to patients in various diagnostic categories, using a
series of discriminant functions. At cross-validation, this
method accurately classified patients’ pain diagnostic cate-
gory 81 % of the time (p<.0001) (Bruns and Disorbio
2003), and this can have some clinical utility. For exam-
ple, Fig. 4 shows the Pain Diagnostic Category analysis
for a patient referred for treatment for TBI-related head-
aches. However, the predicted pain diagnostic category
was “neck injury,” as this distribution of pain reports
was a better match for that diagnostic category. This could
suggest alternative treatment approaches, or different cau-
sality of the pain symptoms.
2 The term “central sensitization” here is derived from current pain theory,
which posits that as pain becomes chronic, it becomes less closely
associated with peripheral sensations. Instead, the central nervous system
becomes sensitized to pain perceptions, resulting in diffuse pain symp-
toms that are associated with affect, arousal, cognition,memory ,and other
factors (Apkarian et al. 2009; Gupta et al. 2007; Melzack and Katz 2006;
Staud et al. 2007).
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Somatic Complaints
Scale Development The items of the Somatic Complaints
scale were selected so that they represented a cross section
of the physical symptomatology associated with psychologi-
cally distressing conditions (e.g., somatization, physical
symptoms of panic, generalized anxiety, and major depres-
sion). Research on the report of somatization symptoms
shows that these symptoms are associated with chronic pain
(Fishbain et al. 2009a) and disability (Harris et al. 2009).
Another study found that somatization predicts suicidality
even when depression is controlled for (Chioqueta and Stiles
2004). Somatization has also been identified by two systemic
reviews as an important predictor of poor outcome from spinal
surgery (Celestin et al. 2009; den Boer et al. 2006)
Scale Interpretation A variety of medical and psychological
conditions are associated with somatic distress. Depression,
anxiety, and pain all have overlapping physical comorbidities
in the form of physiological arousal, fatigue, difficulty con-
centrating, loss of libido, and similar symptoms. A high score
on the Somatic Complaints scale suggests that the patient is
very somatically distressed. This scale is only moderately
bidirectional, but low scores nevertheless suggest that the
patient is unusually symptom free and could be concerned
about reporting physical weaknesses or vulnerabilities.
Validity Research High BHI 2 Somatic Complaints scale
scores are associated with having an uncertain diagnosis
(Fishbain et al. 2010a), with fearing that the physician has
missed something important (Fishbain et al. 2010a), with
feeling entitled to medical care at no cost (Fishbain et al.
2014c), with frequent suicidal thoughts (Fishbain et al.
2012b), with having a suicide plan (Fishbain et al. 2012b),
with a history of suicide attempt (Fishbain et al. 2012b), with
litigious ideation in patients with acute pain (Fishbain et al.
2008), and with pain severity (Fishbain et al. 2014d). Recent
research has hypothesized that somatic complaints such as
these are perhaps better conceptualized as comorbidities of
chronic pain, which are closely associated with the pain syn-
drome (Fishbain et al. 2014a).
Functional Complaints
Scale Development In contrast to measures such as the
Oswestry (Fairbank and Pynsent 2000), or the SF-36
Function Scale (Ware et al. 1993), which measure physical
impairment (such as howmuch you can lift or how far can you
can walk), the BHI 2 Functional Complaints scale is focused
on assessing the perception of disability. This involves the
belief that one is unable to be gainfully employed and unable
to adequately perform activities of daily living, whatever that
might entail. Functioning was identified by two systemic
reviews as an important predictor of poor outcome from spinal
surgery (Celestin et al. 2009; den Boer et al. 2006) and is the
outcome goal for most treatments in physical medicine.
Interpretation Patients with high scores on Functional
Complaints perceive themselves as being disabled and unable
to function at work, home, or both. Functional Complaints is a
bidirectional scale, and patients with low scores are denying
that they have functional limits. When possible, the interpre-
tation of the Functional Complaints scale should be performed
in conjunction with whatever medical information is available
about the patient’s objective ability to function. If there are
large discrepancies between the patient’s perceived and actual
physical abilities, the greater these discrepancies, the more
likely it is that the perceptions of disability are attributable to
an unrealistic cognitive appraisal of physical limitations.
Validity Research High scores on the BHI 2 Functional
Complaints scale are associated with a perceived need of pain
medication (Bruns et al. 2013), feeling entitled to medical care
at no cost (Fishbain et al. 2014c), and breakthrough pain
(Portenoy et al. 2010). The BHI 2 Functional Complaints
scale has strong negative correlation (−.62) with the SF 36
Function scale, which measures functional ability rather than
disability (Bruns and Disorbio 2003).
Muscular Bracing
Scale Development Muscle tension has been called the most
discriminative symptom of generalized anxiety disorder.
However, muscle tension has a complex relationship with
anxiety, and perceptions of muscle tension may be either
objectively true or subjectively perceived (Pluess et al.
2009). Perceived muscle tension is associated with diffuse
subjective feelings of “tension,” which may be physical or
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to assess this experience of feeling tense. The items on the
scale were generated based on item content, refined using an
internal consistency method, and subsequently investigated in
the empirical studies listed below.
Interpretation Patients with high scores on muscular bracing
are reporting perceptions of chronic problems with muscle
tension and being perceived by others as tense persons. This
may be objectively true, or may correspond with a subjective
sense of tension, which is perceived as being muscular in
nature but may actually be more closely associated with
anxious arousal. The Muscular Bracing scale is almost per-
fectly normally distributed, with low scores indicating reports
of a complete lack of muscle tension and being perceived by
others as being unusually relaxed.
Validity Research The Muscular Bracing scale correlated to
.65 with the Anxiety (ANX) scale of the MMPI-2. In addition,
the Muscular Bracing scale correlated to .68, .59, .60, and .52
with the BHI 2 Somatic Complaints, Anxiety, Depression, and
Hostility scales, respectively. High BHI 2 Muscular Bracing
scale scores are associated with having an uncertain diagnosis
(Fishbain et al. 2010a), with pain catastrophizing (Bruns et al.
2013), with a history of childhood molestation in females with
chronic pain (Fishbain et al. 2014b), and with wanting to die
because of pain (Fishbain et al. 2012a). In one study, Muscular
Bracing was the strongest predictor of both delayed sleep
onset and of unrefreshing sleep (Bruns and Bruns 2011).
Affective Scales
It has been estimated that about 30 % of the variance in
psychological tests results was attributable to difficulties with
physical functioning (Naliboff et al. 1982), and as a result,
many psychological tests are influenced heavily by a disease
or injury, its sequelae, and medication side effects as opposed
to the patient’s psychological condition (Turk and Melzack
1992). When constructing the BHI, controlling for such false
positive findings was a priority.
The assessment of depression and anxiety is particularly
confounded by medical symptomatology. In order to control
for this, the BHI 2 includes two separate measures for both
depression and anxiety. The BHI 2 Depression and Anxiety
scales focus on thoughts and feelings, and measure what could
be thought of as phenomenological depression/anxiety. Two
separate measures, Vegetative Depression and Autonomic
Anxiety, are subscales of Somatic Complaints and include
the physical symptoms of depression and anxiety, respectively
(e.g., fatigue, weight change, loss of libido, and racing heart).
The advantage of this strategy is to reduce the risk of false
positive findings on the Depression and Anxiety scales due to
physical symptoms of medical illness. The disadvantage of
this approach is that by dividing both depression and anxiety
assessment into two separate scales, neither scale contains the
entire diagnostic criteria. However, when both Depression/
Vegetative Depression measures are elevated, or Anxiety/
Autonomic Anxiety measures are elevated, this suggests that
cognitive, affective, and physiological symptoms of these
conditions are all present.
Depression
Scale Development Depression is an important variable to
measure in patients with chronic pain, as there is a high
prevalence of depressive symptoms in those with pain. The
BHI 2 Depression scale differs from most others in that it also
includes items pertaining to sad thoughts and feelings associ-
ated with physical health problems. Depression was identified
by two systemic reviews as an important predictor of poor
outcome from spinal surgery (Celestin et al. 2009; den Boer
et al. 2006).
Scale Interpretation A high score on the BHI 2 Depression
scale indicates that the patient is aware of feeling subjectively sad
and depressed and is reporting feelings of helplessness, difficul-
ties with adjusting to health changes, bitter disappointment with
health, anhedonia, and thoughts of suicide. In contrast, this scale
is moderately bidirectional, and a low score on Depression
indicates that the patient is denying having sad feelings or
negative thoughts and is reporting believing that the future seems
bright, feels energetic and optimistic, and feels that life is easy
and satisfying. If a patient was reporting a serious medical
problem, low scores would seem counterintuitive and could
possibly reflect denial or alexithymic tendencies.
Validity Research The BHI 2 Depression scale correlated to
.70 with the MMPI-2 Depression (D) scale, to .71 with the
MCMI-III Dysthymic Disorder (D) scale, and to .67 with the
MCMI-III Major Depression (CC) scale. High BHI 2
Depression scores have been associated with wanting to die
(Fishbain et al. 2012b), with wanting to die because of pain
(Fishbain et al. 2012b), with wanting to die because life is hard
(Fishbain et al. 2012b), with frequent suicidal thoughts
(Fishbain et al. 2012b), with having a suicide plan (Fishbain
et al. 2012b), with thoughts of suing a physician in acute
patients (Fishbain et al. 2008), with thoughts of killing a
physician (Bruns et al. 2010), with feeling entitled to not have
to wait to see a physician (Fishbain et al. 2014c), with failure
to make functional improvements during interdisciplinary
treatment (Freedenfeld et al. 2002), and with breakthrough
pain (Portenoy et al. 2010).
Anxiety
Scale Development The construct that the BHI 2 Anxiety
scale might be most closely associated with is DSM-5
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Illness Anxiety, and to a lesser extent with fear avoidance.
This scale includes items pertaining to worried and fearful
thoughts and feelings associated with physical health prob-
lems, illness, and injury, including fears of dying. Anxiety was
identified by two systemic reviews as an important predictor
of poor outcome from spinal surgery (Celestin et al. 2009; den
Boer et al. 2006)
Interpretation High scores on the Anxiety scale suggest a
person who is feeling fearful, restless, engages in self-
protective behaviors, can have hypochondriacal fears of ill-
ness, is prone to worrying, has multiple health fears, and
worries that the medical condition may somehow lead to
death. Patients with high scores also have social fears as well.
In contrast, patients with low scores on the anxiety scale are
reporting being untroubled by worries or health concerns, not
worrying about behaviorally guarding themselves so as to
avoid injury, and not worrying about contracting illnesses.
The BHI 2 Anxiety scale has a moderately bidirectional
distribution.
Validity Research The BHI 2 Anxiety scale correlated to .54
with the MMPI-2 Anxiety (ANX) scale. High BHI 2 Anxiety
scale scores are associated with having an uncertain diagnosis
(Fishbain et al. 2010a), with fearing that the physician has
missed something important (Fishbain et al. 2010a), and with
feeling entitled to not have to wait to see a physician (Fishbain
et al. 2014c).
Hostility
Scale Development The assessment of hostility was believed
to be an important scale to include on the BHI 2, as anger and
anxiety are the two components of the fight or flight response.
A review of the concept of hostility revealed that it is broken
down into three components: angry feelings, cynical thoughts,
and aggressive behaviors (Barefoot 1992). The BHI 2
Hostility scale was constructed with items representing all
three of these components.
Interpretation High scores on the Hostility scale suggest a
patient who has cynical thoughts about others, is prone to
anger and irritability, is quick to take offense, and can respond
to frustration with an irritable or even belligerent manner. Low
scores on the Hostility scale indicates that the person is
reporting having faith in the kindness of others and being
patient, long-suffering, and easy-going or passive. As with
low scores generally, unusually low reports of hostility can be
the product of an accurate self-report, denial, dissociation, or
alexithymic tendencies.
Validity Research High BHI 2 Hostility scores have been
associated with feelings of anger (Fishbain et al. 2011c), with
chronic anger (Fishbain et al. 2011c), with thoughts of killing
a physician in patients (Bruns et al. 2010), with violent idea-
tion generally (Bruns and Disorbio 2000; Bruns et al. 2007),
with thoughts of homicide/suicide (Fishbain et al. 2011b),
with frequent suicidal thoughts (Fishbain et al. 2012b), with
thoughts of suing a physician (Fishbain et al. 2007), with
feeling entitled to not have to wait to see a physician
(Fishbain et al. 2014c), with wanting to be totally pain free
(Bruns et al. 2013), and with being oppositional (Bruns et al.
2013).
Characterological Dysfunction Scales
The prevalence rate of personality disorder in the gen-
eral population has been estimated as being between 5.9
and 13.5 % (Dersh et al. 2002). In contrast, in five
studies of patients with chronic pain, the prevalence rate
of personality disorder ranged from 40 to 77 % (Dersh
et al. 2006; Fishbain et al. 1986; Large 1986; Okasha
et al. 1999; Polatin et al. 1993). The DSM-5 uses the
concept of the “general personality disorder” to broadly
describe the maladaptive traits that underlie all person-
ality disorders (American Psychiatric Association 2013).
The criteria for the general personality disorder involve
two clusters of traits, with the first cluster of traits
being those involving emotional dysfunction and inter-
personal conflict (represented by the BHI 2 Borderline
scale), and the second cluster of traits involving a
history of poor impulse control and impairment in social
functioning, occupational achievement, and other areas
of function (represented by the BHI 2 Chronic
Maladjustment scale).
With regard to the assessment of personality disorders in
patients with chronic pain, a caveat here is that a recent study
suggested that following the onset of chronic pain patients
may exhibit increased characterological dysfunction, which
may in turn decrease if the pain is treated effectively (Fishbain
et al. 2006).
Borderline
Scale Development By averaging the prevalence rates report-
ed by eight separate studies, one study estimated that 30 % of
patients with chronic pain also suffer from borderline person-
ality disorder (Sansone and Sansone 2012). This study went
on to conclude that patients with borderline personality report
higher levels of pain, theorizing that these patients may have
difficulty with self-regulating pain and may use the pain
syndrome to solicit care from others. The items on the BHI
2 Borderline scale were generated based on item content. The
Borderline scale items focus on aspects of this characterolog-
ical disturbance that were thought to be especially relevant to
the physical rehabilitation setting. This included the loss of
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identity, self-destructive behaviors, and a tendency to develop
highly conflicted relationships with others (splitting). This
scale was refined using an internal consistency method and
subsequently investigated in the empirical studies listed
below.
Interpretation High scores on the Borderline scale indicate
patients who report low self-esteem, difficulty regulating their
moods, an intolerance for frustration, a history of conflicted
relationships with others, and a tendency to punish themselves
for their own perceived weaknesses or defects. This is a
moderately bidirectional scale, and low scores reflect claims
of an unusual absence of conflict or mood variations, which
could be explained by excellent mental health and a strong
support system, or alternately by an avoidance or denial of
conflict.
Validity Research The BHI 2 Borderline scale correlated
to .62 with the MCMI-III Borderline scale, to .60 with
the MMPI 2 Anxiety (ANX) scales, and to .61 with the
MCMI-III Anger (ANG) and Family Problems (FAM)
scales. High BHI 2 Borderline scores have been associ-
ated with wanting to die (Fishbain et al. 2012b), with
wanting to die because life is hard (Fishbain et al.
2012b), with frequent suicidal thoughts (Fishbain et al.
2012b), with having a suicide plan Fishbain et al.
(2012b), with a history of suicide attempt (Fishbain
et al. 2012b), with a preference for death over disability
(Fishbain et al. 2012a), with chronic anger (Fishbain
et al. 2011c), with thoughts of killing a physician
(Bruns et al. 2010), with violent thoughts generally
(Bruns and Disorbio 2000), with thoughts of homicide/
suicide (Fishbain et al. 2011b), with thoughts of suing a
physician (Fishbain et al. 2007), and with medication
nonadherence (Fishbain et al. 2010b).
Chronic Maladjustment
Scale Development The BHI 2 Chronic Maladjustment scale
utilizes items inquiring about a history of difficulties in school,
unstable relationships, vocational instability, unstable living
arrangements, financial irresponsibility, impulsivity, failed life
plans, reckless disregard for safety, and incarceration. This
scale has considerable diagnostic overlap with antisocial per-
sonality. The items of the Chronic Maladjustment scale do not
tap the violent aspects of antisocial personality but do focus on
the inability to attain common milestones of successful adult
functioning seen in general, antisocial, and other personality
disorders as well.
Interpretation Patients with high scores on the Chronic
Maladjustment scale have reported a history of irresponsible
and impulsive behavior, and of failing to succeed in legal,
financial, educational, employment, relationship, and other
aspects of responsible adult life. These patients may be at
greater risk for failing to succeed in a demanding rehabilita-
tion program as well. This scale is moderately bidirectional,
and low scores indicate that the patient is claiming success in
achieving most common milestones of a stable adult life, and
to be a responsible social achiever who lives a conventional
life.
Validity Research The Chronic Maladjustment scale was cor-
related to .62 with the MCMI-III Antisocial (6A) scale, to .46
with the MMPI-2 Psychopathic Deviate (Pd) scale, and to .57
and .55 with the MCMI-III Alcohol Dependence and
Borderline scales, respectively. The Chronic Maladjustment
scale was also associated with a preference for death over
disability (Fishbain et al. 2012a), and noncompliance with
medication (Bruns et al. 2013).
Symptom Dependency
Scale Development The DSM-IV, DSM-5, and ICD 10 all
discuss somatizing disorders with regard to the adoption of a
dependent role, which revolves around the patient’s somatic
complaints. With regard to somatic symptom disorders, the
DSM-5 states that “health concerns may assume a central role
in the individual’s life, becoming a feature of his or her
identity and dominating interpersonal relationships”
(American Psychiatric Association 2013; p. 311). In a discus-
sion of somatoform disorders, the DSM-IV states this some-
what more succinctly, stating that some somatoform disorders
can lead to “dependency and the adoption of a sick role”
(American Psychiatric Association 2000; p. 495). The BHI 2
Symptom Dependency scale was not intended to assess de-
pendent personality per se, but rather to assess how some
patients utilize their symptoms to form dependent attach-
ments. The items on the BHI 2 Symptom Dependency scale
were generated based on item content and were refined using
an internal consistency method and subsequently investigat-
ed in the empirical studies listed below. Passive coping
was identified by two systemic reviews as an important
predictor of poor outcome from spinal surgery (Celestin
et al. 2009; den Boer et al. 2006).
Interpretation Patients with high scores on the Symptom
Dependency scale are reporting symptoms that are refractory
to medical care, associated with life stressors, and for which
they feel entitled to the support of others. This scale is mod-
erately bidirectional, and low scores indicate reports that when
suffering from medical problems, the patient wants to be left
alone.
Validity Research The BHI 2 Symptom Dependency scale is
correlated to .54, .48, .44, and .44 with the MMPI-2 Hysteria–
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Obvious (HyO) scale, Anxiety (A) scale, Addiction Potential
Scale (APS), and Negative Treatment Indicators (TRT) scales,
respectively. High scores on the BHI 2 Symptom Dependency
scale are associated with decreased likelihood of employment
in the 6 months following interdisciplinary treatment
(Freedenfeld et al. 2002), with medical entitlement (Fishbain
et al. 2014c), with violent ideation (Bruns et al. 2007), with
being demanding (Bruns et al. 2013), and with sleep distur-
bance and frequent awakenings (Bruns and Bruns 2011). Very
high Symptom Dependency scores have been identified as a
possible indication of malingering (Rogers 2008).
Substance Abuse
Scale Development The majority of studies of risk factors for
poor medical recovery list substance abuse as a concern
(Bruns and Disorbio 2009), with up to half of patients hospi-
talized for traumatic injury being intoxicated at the time of the
injury, and two thirds having a history of substance abuse
(Corrigan 1995). The Substance Abuse scale is composed of
two blocks of items. The first block inquires into a history of
abusing alcohol and other substances, while a second set of
items assesses current dependence on prescriptionmedication.
This latter block of items differentiates this scale from most
other substance abuse scales. A remote history of substance
abuse increases the risk that an injury will result in disability
(Upmark et al. 1999).
Interpretation A high score on the Substance Abuse scale
indicates that the patient is admitting a history of difficulties
associated with chemical dependency, and current problems
with prescription medication. This admission does not mean
that the patient is currently suffering from addiction, but it
may increase the risk that the patient would revert to chemical
dependency as a means of coping with a medical problem.
This scale is marginally bidirectional, and a low score indi-
cates that the patient denies that his or her use of substances
has ever been inappropriate or caused problems.
Validity Research The BHI 2 Substance Abuse scale correlat-
ed to .55 with the MMPI-2 Addiction Admission Scale
(AAS), and to .40 with the MCMI-III Alcohol Dependence
(B) scale. The content of the BHI 2 Substance Abuse scale
differs from that of the aforementioned alcohol and drug
addiction scales in that it does not have items about addictive
personality traits and includes some items about addiction to
prescription medication. High scores on this scale are associ-
ated with medication nonadherence (Fishbain et al. 2010b),
and violent ideation (Bruns et al. 2007). A high score on this
scale also predicted a decreased likelihood of employment in
the 6 months following interdisciplinary treatment
(Freedenfeld et al. 2002).
Perseverance
Scale Development The concept behind the BHI 2
Perseverance scale combines the literature of several positive
psychological variables, which are optimism (Novy et al.
1998), psychological hardiness (Callahan 2000; Kobasa
et al. 1982), and self-efficacy (Bandura 1992). This scale
contains items representing optimism, hardiness, and self-
efficacy, was refined using an internal consistency method,
and subsequently investigated in the empirical studies listed
below
Interpretation High scores on the Perseverance scale indicate
that the patient is reporting self-discipline, emotional resil-
ience, and proactive conduct. Very high scores are empirically
unusual and may involve exaggerated virtue or stubbornness.
Perseverance is highly bidirectional, with negative T scores
being possible (which occurs when a T score is more than 5
standard deviations below the mean). Low Perseverance
scores indicate that the patient is reporting poor self-discipline,
poor emotional coping, dysfunctional conduct, and
helplessness
Validity Research The BHI 2 Perseverance scale correlates
strongly (.51) with the MMPI-2 Ego Strength (Es) scale.
These scales are similar in that the Ego Strength scale assesses
traits that include being reliable, determined, and self-confi-
dent, while the Perseverance scale measures feelings of opti-
mism, hardiness, and self-efficacy. The Perseverance scale is
also negatively correlated (−.62) with the MMPI-2 Negative
Treatment Indicators (TRT) scale. Extremely high
Perseverance scores (thus claiming excessive virtue) have
been identified as a possible indication of malingering
(Rogers 2008). Low BHI 2 Perseverance scale scores are
associated with feelings of anger (Fishbain et al. 2011c), with
wanting to die because life is hard (Fishbain et al. 2012b), with
frequent suicidal thoughts (Fishbain et al. 2012b), with a
preference for death over disability (Fishbain et al. 2012a),
with having an uncertain diagnosis (Fishbain et al. 2010a),
with medication nonadherence (Fishbain et al. 2010b), and
with fearing that the physician has missed something impor-
tant (Fishbain et al. 2010a).
Social Dysfunction Scales
The third part of the BHI 2 biopsychosocial assessment in-
volves the assessment of social factors. The importance of
social support for the medical patient was established by a
meta-analysis, which found that a supportive family substan-
tially improved patient adherence with treatment (DiMatteo
2004). Similarly, on the other hand, another study found that
social support was associatedwith decreased patient stress and
improved quality of life following surgery (Laxton and Perrin
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2003). Conversely, other studies have found that somatization
is more likely to occur when social conflicts are present (Liu
et al. 2011). In the BHI 2 social dysfunction scales, we
explored the primary social domains relevant to the injured
patient, which are the relationships with the family, the phy-
sician, and the employer. Additionally, this part of the test
assesses signs of a traumatic social history.
Family Dysfunction
Scale Development The Family Dysfunction scale assesses
the patient’s relationship to family, and the degree of support
that may be available. When a patient is recovering from an
injury or illness, typically it is the family to which the patient
turns for support during this difficult time. However, if the
family is cold, uncaring, or abusive, or if family relationships
are highly conflicted, this increases the stress on the patient.
Research suggests that a supportive family can facilitate re-
covery during a time when patients may be considerably less
functional, and more reliant on others (Abbasi et al. 2012;
Elkayam et al. 1996). In contrast, a dysfunctional or
nonsupportive family (which is being reported when there is
a high score on the Family Dysfunction scale) can make the
patient’s circumstances during rehabilitation especially diffi-
cult, and might increase the risk of poor recovery.
Interpretation High scores on the Family Dysfunction scale
are indicative of patients who report feeling unloved, unsup-
ported, mistreated, or angered by their families. Perceptions
such as these may give rise to feelings of insecurity, isolation,
and vulnerability in the injured or physically ill patient. Given
the intensity of conflicts present, these patients may rely
heavily on their medical caregivers for meeting their security
and support needs.
Validity Research The Family Dysfunction scale correlated
highly (.70) with the MMPI-2 Family Problems (FAM) scale.
High BHI 2 Family Dysfunction scale scores are asso-
ciated with medication nonadherence (Fishbain et al.
2010b), and with a preference for death over disability
(Fishbain et al. 2012a).
Survivor of Violence
Scale Development A series of US Centers for Disease
Control studies have demonstrated a relationship between
adverse childhood experiences (ACE), and morbidity and
mortality decades later (Felitti et al. 1998). Other studies have
identified a relationship between ACE and the appearance in
adulthood of back pain (Schofferman et al. 1993), poor surgi-
cal outcome (Schofferman et al. 1992), and conversion disor-
der or somatization (Andreski et al. 1998; Kaplan et al. 2013;
Ozcetin et al. 2009). PTSD in adulthood has also been shown
to be associated with chronic pain (Morasco et al. 2013). The
Survivor of Violence scale is composed of items describing a
variety of traumatic experiences occurring in both childhood
and adulthood.
Interpretation High scores on the Survivor of Violence scale
indicate an extensive history of physically or psychologically
traumatic experiences. Patients with high scores are reporting
that they have survived multiple traumatic events in their past.
This scale is only marginally bidirectional, and low scores
indicate that the patient is not reporting any lifetime history of
psychological trauma.
Validity Research Despite the fact that the majority of the BHI
2 Survivor of Violence scale items make no reference to
family, it nevertheless correlated to .72 with the BHI 2
Family Dysfunction scale, to .55 with the MMPI-2 Family
Problems (FAM) scale, and to .54 with the BHI 2 Borderline
scale. High scores on the Survivor of Violence scale were
associated with a history of a suicide attempt (Fishbain et al.
2011), noncompliance with medication (Bruns et al. 2013),
and with litigious ideation (Bruns et al. 2013).
Doctor Dissatisfaction
Scale Development When developing the BHI 2, it was hy-
pothesized that if the patient has a highly positive view of the
physician, or even thinks the physician is OK, it is unlikely to
impair prognosis. However, if a patient comes to hate the
physician, and to see the physician as an unempathic agent of
an uncaring health care system, who is incompetent and only in
for the money, then that may threaten the recovery process.
Interpretation High scores on the Doctor Dissatisfaction scale
indicate an unusual level of frustration and anger with the
medical profession. Patients with elevated scores are reporting
perceptions of physicians as unempathic and incompetent.
This scale is moderately bidirectional, and low scores indicate
a positive description of the physician. While this could sug-
gest a positive therapeutic alliance, it could also be attributable
to a reluctance to criticize an authority figure upon which one
is dependent.
Validity Research High BHI 2 Doctor Dissatisfaction scale
scores are associated with having an uncertain diagnosis
(Fishbain et al. 2010a), with fearing that the physician has
missed something important (Fishbain et al. 2010a), with
medical entitlement (Fishbain et al. 2014c), with more high-
risk patient behaviors than any other tested risk factor (Bruns
et al. 2013), with thoughts of suing a physician (Fishbain et al.
2007, 2008), with thoughts of killing a physician (Bruns et al.
2010), and with thoughts of homicide/suicide (Fishbain et al.
2011b).
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Job Dissatisfaction
Scale Development Although the BHI 2 Job Dissatisfaction
scale was created in the context of workers’ compensa-
tion and other disability systems, it also applies to
patients who are in the workforce. If a patient is injured
while at work, having pain can allow a worker to
escape from an undesirable job, receive pay while off
of work, resume work with reduced duties, force the
employer to make accommodations, receive opioid pain
medication, receive desirable treatments, and if they fail
to recover, receive monetary compensation for not get-
ting better. Thus, when recovery means return to work,
Job Dissatisfaction can be a significant predictor of poor
outcome. Job Dissatisfaction was identified by a sys-
temic review as an important predictor of poor outcome
from spinal surgery (den Boer et al. 2006).
One study found that job dissatisfaction was the strongest
predictor of reporting a workplace injury (Bigos et al. 1992),
and of subsequent higher levels of pain (Davis and Heaney
2000). The Job Dissatisfaction scale has four subscales, de-
scribing dissatisfaction with the company, supervision, co-
workers, and with the intrinsic nature of the job itself.
Interpretation Patients with high scores on the Job
Dissatisfaction scale reported feelings of resentment to-
ward their employer. These patients may have higher
demands for accommodation and may be at risk for
conflict with supervisors. If recovery means returning
to an unpleasant or disliked workplace, it may interfere
with the patient’s motivation in rehabilitation. This scale
is moderately bidirectional, and low scores indicate that
the patient is reporting feeling satisfied with his/her
employment.
Validity Research The BHI 2 Job Dissatisfaction scale is
negatively correlated (−.64) with the Minnesota Satisfaction
Questionnaire (MSQ). Although the MSQ does not tap the
depth of animosity that the BHI 2 Job Dissatisfaction scale
does, the two scales both measure job-related attitudes and
feelings. A high score on this scale was associated with an
increased likelihood of undergoing surgery in the 6 months
following interdisciplinary treatment (Freedenfeld et al. 2002).
The Brief Battery for Health Improvement 2
The BHI 2 has a companion short form, called the BBHI 2.
While the longer BHI 2 takes 30 to 35 min to administer, the
BBHI 2 can be administered in about 10 min. The BBHI 2 is
composed of six scales: Defensiveness, Pain Complaints,
Somatic Complaints, Functional Complaints, Depression,
and Anxiety. Of these, three (Defensiveness, Pain
Complaints, and Functional Complaints) are identical to the
scales on the longer BHI 2. The other three scales (Somatic
Complaints, Depression, and Anxiety) are shortened versions
of the longer BHI 2 scales, which intercorrelated very highly
with the longer versions. The BBHI 2 Somatic Complaints
scale correlates with the BHI 2 version to .96, the BBHI 2
Depression scale correlates with the BHI 2 version to .95, and
the BBHI 2 Anxiety scale correlates with the BHI 2 version to
.91.
The BBHI 2 Somatic Complaints, Depression, and Anxiety
scales are different from their longer BHI 2 counterparts in one
important respect. In contrast to the longer scales on the BHI
2, which includes both transient “state” type items with more
enduring “trait” type items, the shortened BBHI 2 scales focus
on state items, as opposed to trait items. The rationale for this
is that the BBHI 2 was intended to be useful in serial assess-
ment, in order to track changes over the course of treatment. In
order to do so, however, it was necessary to focus on state
items (e.g., “I feel sad”) as opposed to trait items (e.g., “I
attempted suicide in the past”). This is because state items are
changeable, whereas trait items are not. By this focusing on
state items, the BBHI 2 scales focused on changeable symp-
tomatology, making them more sensitive to change in re-
sponse to treatment. It should be noted that the BBHI 2 scales
can be scored from the longer BHI 2 administration.
The BBHI 2 also screens for a wide variety of difficulties
through the use of critical items. The psychological concerns
screened for by the BBHI 2 include suicidality, addiction,
psychosis, death fears, panic, dissociation, satisfaction with
care, family problems, insomnia, home life problems, dys-
functional pain cognitions, compensation focus, and other
concerns.
Presurgical and Pre-opioid Assessments
In the forensic setting, examiners are sometimes asked to form
an opinion about the prognosis of a patient for benefitting from
a surgery or other treatment. To this end, the BHI 2 can be
employed to produce scores for several different presurgical or
pre-opioid treatment assessment protocols. These protocols
were developed for various purposes by different methods,
and each has their own unique strengths and weaknesses.
Presurgical Psychological Assessments
From the standpoint of the strongest scientific evidence, the
two presurgical protocols with the highest level of evidence
are based on the systematic reviews of psychosocial risk
factors conducted by den Boer and colleagues (den Boer
et al. 2006), and by Celestin and colleagues (Celestin et al.
2009). These two studies produced very similar results and
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share two weaknesses. First of all, neither den Boer nor
Celestin suggests any means of performing a presurgical
assessment. Thus, while they are very informative theoretical-
ly, neither study made any suggestions about translating their
findings into clinical practice.
A second weakness of the den Boer and Celestin studies
can be understood by considering the conclusions of expert
panels that made recommendations about presurgical psycho-
social risk factors for spinal cord stimulators (Bruns and
Disorbio 2009). This study reported a clinical consensus that
the most important risk factors to identify were those having to
do with severe psychopathology, such as being suicidal, ho-
micidal, psychotic, and addicted. Unfortunately, there are no
randomized controlled trials (RCTs) assessing the outcome of
back surgery on patients who are also suffering from any kind
of severe psychopathology. As there are no such studies in the
literature, the den Boer and Celestin studies had nothing to
review, and they made no recommendations about severe
psychopathology. Because of these limits to the research
literature, if a patient was diagnosed with antisocial personal-
ity, cocaine addiction, paranoia, homicidality, had threatened
the physician, and had a history of making fraudulent medical
claims to obtain opioids, that patient would have no psycho-
social risk factors using either the den Boer or Celestin
protocols.
In contrast to the den Boer and Celestin scientific studies,
Block and colleagues (Block et al. 2003; Block et al. 2001;
Epker and Block 2001) and Bruns and Disorbio (Bruns and
Disorbio 2009, 2013) developed clinically oriented protocols.
These protocols for the most part subsume the den Boer and
Celestin criteria, while adding more serious signs of psycho-
pathology. In contrast to den Boer’s and Celestin’s ap-
proaches, Block’s translational science method integrates psy-
chological testing and educational information for psycholo-
gists about the surgical procedures involved, along with an
integrated clinical algorithm.
Using a different methodology than Block and colleagues,
the Bruns and Disorbio review produced a two-tiered set of
risk factors coupled with a clinical assessment method. The
first tier was of moderate risk factors similar to Block’s criteria
in many respects, and like Block, it subsumed the den Boer
and Celestin criteria. However, the Bruns and Disorbio study
also identified a separate set of severe “exclusionary” or
“primary” risk factors, any one of which is widely held to be
so behaviorally disruptive as to create grave concerns about a
patient’s ability to benefit frommedical treatments (Bruns and
Disorbio 2009). While there are no meta-analyses, systematic
reviews, or RCTs of any of these primary risk factors, some
empirical studies of these extreme risk factors have recently
been published. These include studies pertaining to suicidal
ideation (Fishbain et al. 2012a; Fishbain et al. 2012b), violent
ideation (Bruns and Disorbio 2000; Bruns et al. 2007),
thoughts of killing a physician (Bruns et al. 2010; Fishbain
et al. 2009a), thoughts of suing a physician (Fishbain et al.
2007, 2008), borderline personality (Tragesser et al. 2010),
medical entitlement (Fishbain et al. 2014c), undefinedmedical
symptoms (Fishbain et al. 2010a), and others.
Both the Block and the Bruns and Disorbio methods have
the advantage of being integrated with assessment methods,
making them practical for clinical use. For example, the two-
tiered approach has been adopted by some evidence-based
medicine guidelines for assessing patients with chronic pain
(Colorado Division of Workers’ Compensation 2012), and
research suggests that this integrated biopsychosocial protocol
appears to deliver better care at a reduced cost (Bruns et al.
2012b). However, practical considerations aside, if the stan-
dards of evidence-based medicine are strictly applied, the den
Boer and Celestin findings have reached a higher standard of
evidence.
An advantage of the BHI 2 is that since it was
designed to assess the full range of relevant psycholog-
ical variables, it is able to perform a standardized as-
sessment of nearly all of the variables identified by den
Boer/Celestin (Meyer et al. 2012a, 2012b), Block
(Disorbio et al. 2012a, 2012b), and Bruns and
Disorbio protocols (Bruns and Disorbio 2009). Using
the BHI 2, preliminary comparisons of several studies
of presurgical psychological evaluation protocols have
been published. These studies included the first evi-
dence of the test-retest reliability of presurgical psycho-
logical evaluation protocols (Bruns et al. 2012a; Bruns
and Disorbio 2009). This information is especially im-
portant in forensic evaluations, as the Daubert standard
of evidence requires that the level of error (i.e., reliabil-
ity) of a method must be known. The results of these
studies showed that using the BHI 2 to assess the den
Boer/Celestin, Block, and Bruns and Disorbio protocols
led to scores that were highly reliable, with test-retest
reliability ranging from .81 to .95. Additionally, all of
these presurgical protocols intercorrelated highly, rang-
ing from .63 to .87. The fact that these four divergent
methods led to the identification of similar criteria and
that the scores intercorrelate strongly is an indication of
convergent validity. However, while these four methods
produce very similar scores and share half or more of
their variance with each other, at the same time, they
are all somewhat different. It should be noted that these
reliability factors are based on a BHI 2 based assess-
ment, and this would not be applicable to other methods
of assessing these protocols.
What can be said about which protocol to use? For a patient
who is free of severe psychopathology, the den Boer/Celestin
methods are supported by the highest level of evidence.
However, these protocols identify only a core set of risk
factors that have been well researched. For a more compre-
hensive assessment of psychopathology, the Block criteria or
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the Bruns and Disorbio criteria have advantages. The Block
protocol has the advantage of having a defined method of
clinical implementation, being the approach mostly closely
associated with a clinical algorithm, having educational ma-
terials for psychologists about surgical procedures, and having
a protocol that distills the information into a useful 1 to 5
rating tied to a clinical decision making tree. In contrast, the
Bruns and Disorbio protocol differs here by having a some-
what more complex method, but one which generates a stan-
dardized score with 1 to 99 percentile ranks based on the BHI
2 norm groups. Suggested cutoffs are above the 84th percen-
tile (1 standard deviation above the mean of patients) for
moderate risk, above the 95th percentile for high risk, and
above the 99th percentile for very high risk. The Bruns and
Disorbio protocol has an important characteristic that it is the
only presurgical protocol with evidence that it has no race or
gender bias (Bruns and Disorbio 2009). It also has established
test-retest reliability for the overall surgical risk estimate, and
of all the protocols, it does more to define and identify severe
psychopathology. Overall, there are several protocols for
assessing psychosocial risk for poor outcome from surgery
and other medical treatments, and the BHI 2 is able to provide
estimates for all of them. This provides the examiner with the
ability to use one test and then afterwards decide which
protocol may be most applicable to a particular situation.
Finally, it is worth noting that there is evidence that the
core set of psychosocial variables identified in these
“presurgical” protocols may also predict the outcome of
other medical treatment as well. For example, one study
found that presurgical psychological risk factor assessment
scores were associated not only with the perception of a
good outcome in spinal surgery patients but also with the
perception of a good outcome in nonspinal surgery pa-
tients, chronic patients, acute pain patients, work hardening
patients, patient litigants, and brain injury patients (Bruns
and Disorbio 2009). This suggests that these risk factors
may apply not only to spinal surgery outcome but also to
the outcome of medical treatments generally.
Pre-opioid Treatment Evaluations
In addition to presurgical psychological evaluations, there are
other types of medical treatment where pretreatment psycho-
logical evaluations are indicated. One of these is a pretreat-
ment psychological evaluation prior to initiating chronic opi-
oid therapy. Aberrant use of opioids has been observed in up
to 24 % of patients (Martell et al. 2007), and the CDC has
recently reported that more accidental overdose deaths involve
opioid analgesics than heroin and cocaine combined (Centers
for Disease Control and Prevention 2012). Not surprisingly,
10 of 13 major opioid guidelines recommend psychological
assessment prior to long-term opioid treatment (Nuckols et al.
2013).
Studies suggest that physicians feel conflicted about
treating chronic pain with opioids. Surveys of physician atti-
tudes have found that physicians feel that chronic noncancer
pain is undertreated, yet at the same time would not prescribe
opioids for this condition (Morley-Forster et al. 2003). This
reluctance of physicians to prescribe opioids is associated
with two related concerns: opioid craving and opioid addic-
tion. With regard to craving, animal studies have demonstrat-
ed that a biological property of opioid medications is that they
induce craving (Bai et al. 2014). In human studies, opioid
craving has been shown to be associated with opioid relapse in
patients who were in treatment for opioid abuse (Tsui et al.
2014) and opioid craving is in turn influenced by both mood
(Martel et al. 2014a) and cognitions (Martel et al. 2014b).
A number of risk factors for opioid abuse have been
identified in the literature, and almost all of them can be
assessed using BHI 2 measures. These include a history of
substance abuse (Akbik et al. 2006; Butler et al. 2009; Butler
et al. 2008; Edlund et al. 2010; Edlund et al. 2007; Fitzcharles
et al. 2011; Green et al. 2009; White et al. 2009), alcoholism
(Fitzcharles et al. 2011; Green et al. 2009), drug treatment
(Akbik et al. 2006; Butler et al. 2009; Butler et al. 2008), any
psychological disorder (Edlund et al. 2010; Edlund et al.
2007; Fitzcharles et al. 2011), depression (Green et al. 2009;
Katz et al. 2013; Manchikanti et al. 2007; White et al. 2009;
Wilsey et al. 2008), suicidality (Fitzcharles et al. 2011; Green
et al. 2009), bad temper (Akbik et al. 2006; Butler et al. 2009;
Butler et al. 2008), history of abuse or PTSD (Akbik et al.
2006; Butler et al. 2009; Butler et al. 2008; White et al. 2009;
Wilsey et al. 2008), anxiety or panic (Manchikanti et al. 2007;
Wilsey et al. 2008), somatization (Manchikanti et al. 2007),
and personality disorder (especially borderline or antisocial)
(Katz et al. 2013; Kosten et al. 1986; Wilsey et al. 2008).
Additionally, social risk factors include tension at home
(Akbik et al. 2006; Butler et al. 2009; Butler et al. 2008),
conflict with the physician (Akbik et al. 2006; Butler et al.
2009; Butler et al. 2008), younger age (Edlund et al. 2010;
Green et al. 2009), low education (Fitzcharles et al. 2011),
unemployment (Fitzcharles et al. 2011), and a history of arrest
(Akbik et al. 2006; Butler et al. 2009; Butler et al. 2008). A
recent study used BHI 2 variables representing the constructs
above and used them to predict both the perceived need for
pain medication and perceived addiction to pain medicine,
identifying the need for medication correctly 73% of the time,
and addiction status correctly 86 % of the time (A. Bruns,
Bruns, Disorbio, and Jewell 2014).
Overall, while pre-opioid psychological assessment proto-
cols are not as well developed as presurgical protocols, there is
ample evidence of the value of these assessments. With regard
to both presurgical and pretreatment evaluations though, the
forensic evaluator should be aware that any of the psycholog-
ical risk scores mentioned here should not be construed as
defining the entire evaluation. While these risk scores are
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important considerations, they should be interpreted within
the context of the patient’s history, medical findings, degree of
surgical necessity, and other relevant factors.
Conclusions
The BHI 2 is a biopsychosocial assessment tool whose devel-
opment was based on a theory of how biological, psycholog-
ical, and social forces interact in patients with serious injury or
illness. While the biopsychosocial model applies to individ-
uals generally, the BHI 2 is especially attuned to the assess-
ment of patients suffering from pain and injury. In the forensic
setting, the BHI 2 can be useful in several ways. First of all, a
BHI 2 assessment can enable the examiner to perform a
biopsychosocial assessment of the patient, which can measure
and describe various subjective phenomena, while controlling
for patient bias of report. This can provide a deeper
understanding of the contributors to the patient’s pain
and suffering, by identifying risk factors that appear to
be pre-existing, ones that may be reasonably attributed
to the onset of a particular medical condition, ones that
are consistent with biologic reports, and ones that are
difficult to explain biologically.
Like all psychological inventories, the BHI 2 has both
strengths and weaknesses. Its strengths include the following:
1. The BHI 2 is a standardized test and was developed based
on a biopsychosocial paradigm that is especially well
suited for assessing patients with injury, chronic pain, or
other somatic symptom disorders.
2. The BHI 2 has both community and patient normative
groups, as well as eight other reference groups which can
be used to make relevant comparisons to address a variety
of clinical questions.
3. The BHI 2 interpretive algorithms integrate community
and patient norms into a single continuum, which pre-
vents problems associated with conflicting findings.
4. Consistent with current psychometric concepts, the BHI 2
and BBHI 2 utilize bidirectional scales.
5. The BHI 2 has a short form, the BBHI 2, which can be
administered in 10 min or less.
6. The BHI 2 and BBHI 2 are the only instruments that
include both a standardized multidimensional measure
of pain and validity assessment.
7. The BHI 2 is the only test that can by itself assess all of the
presurgical assessment criteria identified by the systemat-
ic reviews of den Boer and Celestin. It also has scales that
directly or approximately measure the presurgical criteria
identified by Block, and by Bruns and Disorbio (exclud-
ing determinations that require medical examination or
chart review).
8. The BHI 2 has a particular strength in assessing pain,
reactions to injury, dysfunctional pain cognitions, and
pain-related psychopathology, including somatization, af-
fective distress, substance abuse, characterological traits,
suicidality, violent tendencies, and litigious tendencies.
The BHI 2 also has significant weaknesses. They are as
follows:
1. In comparison to the MMPI-2-RF, the BHI 2’s validity
assessment is not as comprehensive. Although the BHI 2
validity scales were developed through a sound clinical
study in a pain and injury population, theMMPI-2-RF has
a larger number of validity scales that have been more
extensively studied in a variety of populations. The
MMPI-2-RF is also able to detect a wider range of psy-
chiatric conditions as this is the test's primary purpose,
versus the BHI 2's focus on biopsychosocial assessment.
2. In comparison to the MBMD, the BHI 2 has more of a
focus on pain and injury, but less ability to assess how a
patient copes with the stress of disease.
3. The independent peer review by the Buros Institute noted
above suggested that the greatest need for future BHI 2
research was for further studies on malingering and lon-
gitudinal outcome studies.
4. While the validity of many of the BHI 2 scales have been
supported by multiple research studies, others have more
limited research support.
5. While most of the BHI 2 scales are based on conventional
constructs, such as depression and anxiety, others are based
on novel constructs, such as symptom dependency, or perse-
verance. Further research is indicated on these novel scales.
6. Aweakness the BHI 2 shares with most inventories is that
there have been no studies regarding the long-term reli-
ability of its scales.
7. As noted previously, the BHI 2 approach to assessing
depression and anxiety has both strengths andweaknesses.
By dividing the assessment of depression into two separate
scales, Depression (thoughts and feelings associated with
depression) and Vegetative Depression (physical symp-
toms associated with depression), the BHI 2 controls for
false positive depressive findings due to reports of medical
symptomatology resembling depression. However, the
weakness with this approach is that the full scope of
depressive symptomatology is thus spread across two
scales, making the assessment of depression somewhat
more complex. This approach thus represents a trade-off
for the assessment of depression, and the same could be
said for the BHI 2 approach to the assessment of anxiety.
Overall, while the BHI 2 has some identified weak-
nesses, its numerous strengths pertaining to the assessment
of patients with pain or injury will enable it to play a useful
role in the forensic psychologist’s toolbox.
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